ClinicalTrials.gov
ClinicalTrials.gov Menu

TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00023387
Recruitment Status : Completed
First Posted : September 10, 2001
Last Update Posted : September 13, 2005
Sponsor:
Collaborator:
VA Office of Research and Development
Information provided by:
Centers for Disease Control and Prevention